Prot# CNTO1959PSO2001: A Phase 2 Multicenter, Randomized, Placebo- and Active-Comparator-Controlled, Dose-Ranging Trial to Evaluate CNTO 1959 for the Treatment of Subjects with Moderate to Severe Plaque-type Psoriasis (X-PLORE)

Project: Research project

StatusFinished
Effective start/end date5/4/125/4/15

Funding

  • Parexel (CNTO1959PSO2001)
  • Janssen Research & Development, LLC (CNTO1959PSO2001)